Literature DB >> 10879596

Neurological complications of varicella-zoster virus infection in adults with human immunodeficiency virus infection.

A De La Blanchardiere1, F Rozenberg, E Caumes, O Picard, F Lionnet, J Livartowski, J Coste, D Sicard, P Lebon, D Salmon-Cèron.   

Abstract

This multicentre retrospective study describes the clinical features and prognostic significance of Varicella-zoster virus (VZV)-associated neurological complications. The study was performed in patients with human immunodeficiency virus (HIV) infection, hospitalized for VZV neurological complications, confirmed in every case by positive VZV polymerase chain reaction (PCR) in cerebrospinal fluid (CSF). Between 1990 and 1995, 34 HIV-infected patients were included in the study. At diagnosis, 59% had AIDS, with a median CD4 count of 11 x 10(9)/l. A past history of zoster was noted in 35% of cases. A concomitant herpes zoster rash and/or acute retinal necrosis were noted in 71% and 12% of patients, respectively. The predominant neurological manifestations were encephalitis (13), myelitis (8), radiculitis (7) and meningitis (6). The mean CSF white blood cell count was 126/mm3 and the mean CSF protein concentration was 2.3 g/l. Interferon-alpha level was increased in 36% of patients. VZV was isolated from CSF cultures in 2/6 cases. Magnetic resonance imaging was abnormal, demonstrating encephalitis lesions. After intravenous antiviral therapy, complete recovery was obtained in 18 cases (53%), serious sequelae were observed in 10 cases (29%) and 6 patients died (18%). Severe symptoms and a low CD4 cell count appeared to be associated with death or sequelae. In conclusion, VZV should be considered as a possible cause of encephalitis, myelitis, radiculitis or meningitis in HIV-infected patients, especially in patients with a history of or concomitant herpes zoster or acute retinal necrosis. VZV-PCR in the CSF may allow rapid diagnosis and early specific antiviral treatment.

Entities:  

Mesh:

Year:  2000        PMID: 10879596     DOI: 10.1080/00365540050165893

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  16 in total

Review 1.  Real-time PCR in clinical microbiology: applications for routine laboratory testing.

Authors:  M J Espy; J R Uhl; L M Sloan; S P Buckwalter; M F Jones; E A Vetter; J D C Yao; N L Wengenack; J E Rosenblatt; F R Cockerill; T F Smith
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

2.  T Cell Immunity to Varicella-Zoster Virus in the Setting of Advanced HIV and Multiple Varicella-Zoster Virus Recurrences.

Authors:  Rachel A Bender Ignacio; Meena S Ramchandani; Kerry J Laing; Christine M Johnston; David M Koelle
Journal:  Viral Immunol       Date:  2016-11-21       Impact factor: 2.257

3.  Subclinical reactivation of varicella zoster virus in all stages of HIV infection.

Authors:  Marius Birlea; Gabriele Arendt; Eser Orhan; D Scott Schmid; William J Bellini; Christian Schmidt; Don Gilden; Randall J Cohrs
Journal:  J Neurol Sci       Date:  2011-03-17       Impact factor: 3.181

4.  Varicella zoster virus encephalomyelitis as a late complication following haematopoietic stem cell transplantation.

Authors:  Lokesh Shahani
Journal:  BMJ Case Rep       Date:  2014-12-19

5.  Neurological complications of varicella-zoster virus in human immunodeficiency virus-infected patients: changes in prevalence and diagnostic utility of polymerase chain reaction in cerebrospinal fluid.

Authors:  Iñigo Corral; Carmen Quereda; Antonio Antela; Vicente Pintado; José Luis Casado; Pilar Martín-Dávila; Enrique Navas; Santiago Moreno
Journal:  J Neurovirol       Date:  2003-02       Impact factor: 2.643

Review 6.  Molecular methods for diagnosis of viral encephalitis.

Authors:  Roberta L Debiasi; Kenneth L Tyler
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

Review 7.  Pathogenesis and current approaches to control of varicella-zoster virus infections.

Authors:  Anne A Gershon; Michael D Gershon
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

8.  [Acute retinal necrosis from the virologist's perspective].

Authors:  P Rautenberg; L Grancicova; J Hillenkamp; B Nölle; J B Roider; H Fickenscher
Journal:  Ophthalmologe       Date:  2009-12       Impact factor: 1.059

Review 9.  Varicella zoster vaccines and their implications for development of HSV vaccines.

Authors:  Anne A Gershon
Journal:  Virology       Date:  2013-01-05       Impact factor: 3.616

10.  Cerebrospinal fluid HIV-1 compartmentalization in a patient with AIDS and acute varicella-zoster virus meningomyeloradiculitis.

Authors:  E Liana Falcone; Ademiposi A Adegbulugbe; Virginia Sheikh; Hiromi Imamichi; Robin L Dewar; Dima A Hammoud; Irini Sereti; H Clifford Lane
Journal:  Clin Infect Dis       Date:  2013-05-31       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.